Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT01882062
PHASE2
Proof of Concept of an Anaplerotic Study Using Brain Phosphorus Magnetic Resonance Spectroscopy in Huntington Disease
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
View on ClinicalTrials.gov
Summary
The purpose of this project is to study the efficacy of an anaplerotic treatment on brain energy profile evolution at an early stage of the Huntington disease.
Official title: ETUDE PREUVE DE CONCEPT D'UNE APPROCHE ANAPLEROTIQUE UTILISANT LA SPECTROSCOPIE RMN CEREBRALE AU PHOSPHORE-31 DANS LA MALADIE DE HUNTINGTON
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2013-05
Completion Date
2013-07
Last Updated
2026-06-11
Healthy Volunteers
No
Conditions
Interventions
DRUG
Triheptanoin 1g/kg/day
Locations (1)
Brain and Spine Institute
Paris, France